Improvements in survival and Clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer : A randomized trial
- Author
- BURRIS, H. A; MOORE, M. J; NELSON, R; DORR, F. A; STEPHENS, C. D; VON HOFF, D. D; ANDERSEN, J; GREEN, M. R; ROTHENBERG, M. L; MODIANO, M. R; CRIPPS, M. C; PORTENOY, R. K; STORNIOLO, A. M; TARASSOFF, P
ACRC/Arizona Clinical Research Center, Tucson, United States
Brooke Army Medical Center, Fort Sam Houston, United States
Cancer Care Center of Southern Arizona, Tucson, AZ, United States
Institute for Drug Development, Cancer Therapy and Research Center, San Antonio, United States
Lilly Research Laboratories, Indianapolis, IN, United States
Memorial Sloan-Kettering Cancer Center, New York, NY, United States
Ontario Cancer Treatment & Research Foundation, Ottawa, Canada
Princess Margaret Hospital, Toronto, Canada
The University of Texas Health Science Center at San Antonio, San Antonio, TX, United States
University of California, San Diego Cancer Center, San Diego, CA, United States - Source
Journal of clinical oncology. 1997, Vol 15, Num 6, pp 2403-2413 ; ref : 41 ref
- ISSN
- 0732-183X
- Scientific domain
- Medical oncology
- Publisher
- Lippincott Williams & Wilkins, Baltimore, MD
- Publication country
- United States
- Document type
- Article
- Language
- English
- Keyword (fr)
- Adénocarcinome Anticancéreux Chimiothérapie Efficacité traitement Fluor Composé organique Gemcitabine Homme Pancréas Pyrimidine nucléoside Randomisation Stade avancé Traitement palliatif Traitement Appareil digestif pathologie Pancréas pathologie Tumeur maligne
- Keyword (en)
- Adenocarcinoma Antineoplastic agent Chemotherapy Treatment efficiency Fluorine Organic compounds Gemcitabine Human Pancreas Pyrimidine nucleoside Randomization Advanced stage Palliative treatment Treatment Digestive diseases Pancreatic disease Malignant tumor
- Keyword (es)
- Adenocarcinoma Anticanceroso Quimioterapia Eficacia tratamiento Fluor Compuesto orgánico Gemcitabina Hombre Páncreas Pirimidina nucleósido Aleatorización Estadio avanzado Tratamiento paliativo Tratamiento Aparato digestivo patología Páncreas patología Tumor maligno
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02R Antineoplastic agents / 002B02R02 Chemotherapy
- Discipline
- Pharmacological treatments
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 2693278
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1200/JCO.1997.15.6.2403 
https://dx.doi.org/10.1200/JCO.1997.15.6.2403
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:26:\"10.1200\/JCO.1997.15.6.2403\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:148:\"Improvements in survival and Clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer : A randomized trial\";s:9:\"\u0000*\u0000jtitle\";s:28:\"Journal of clinical oncology\";s:9:\"\u0000*\u0000stitle\";s:14:\"J. clin. oncol\";s:7:\"\u0000*\u0000date\";s:4:\"1997\";s:9:\"\u0000*\u0000volume\";s:2:\"15\";s:8:\"\u0000*\u0000issue\";s:1:\"6\";s:8:\"\u0000*\u0000spage\";s:4:\"2403\";s:8:\"\u0000*\u0000epage\";s:4:\"2413\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0732-183X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"BURRIS\";s:10:\"\u0000*\u0000aufirst\";s:4:\"H. A\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:13:{i:0;s:11:\"MOORE, M. J\";i:1;s:9:\"NELSON, R\";i:2;s:10:\"DORR, F. A\";i:3;s:14:\"STEPHENS, C. D\";i:4;s:14:\"VON HOFF, D. D\";i:5;s:11:\"ANDERSEN, J\";i:6;s:11:\"GREEN, M. R\";i:7;s:16:\"ROTHENBERG, M. L\";i:8;s:13:\"MODIANO, M. R\";i:9;s:12:\"CRIPPS, M. C\";i:10;s:14:\"PORTENOY, R. K\";i:11;s:15:\"STORNIOLO, A. M\";i:12;s:12:\"TARASSOFF, P\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:148:\"Improvements in survival and Clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer : A randomized trial\";s:8:\"\u0000*\u0000place\";s:13:\"Baltimore, MD\";s:6:\"\u0000*\u0000pub\";s:29:\"Lippincott Williams & Wilkins\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:26:\"10.1200\/JCO.1997.15.6.2403\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:148:\"Improvements in survival and Clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer : A randomized trial\";s:9:\"\u0000*\u0000jtitle\";s:28:\"Journal of clinical oncology\";s:9:\"\u0000*\u0000stitle\";s:14:\"J. clin. oncol\";s:7:\"\u0000*\u0000date\";s:4:\"1997\";s:9:\"\u0000*\u0000volume\";s:2:\"15\";s:8:\"\u0000*\u0000issue\";s:1:\"6\";s:8:\"\u0000*\u0000spage\";s:4:\"2403\";s:8:\"\u0000*\u0000epage\";s:4:\"2413\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0732-183X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"BURRIS\";s:10:\"\u0000*\u0000aufirst\";s:4:\"H. A\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:13:{i:0;s:11:\"MOORE, M. J\";i:1;s:9:\"NELSON, R\";i:2;s:10:\"DORR, F. A\";i:3;s:14:\"STEPHENS, C. D\";i:4;s:14:\"VON HOFF, D. D\";i:5;s:11:\"ANDERSEN, J\";i:6;s:11:\"GREEN, M. R\";i:7;s:16:\"ROTHENBERG, M. L\";i:8;s:13:\"MODIANO, M. R\";i:9;s:12:\"CRIPPS, M. C\";i:10;s:14:\"PORTENOY, R. K\";i:11;s:15:\"STORNIOLO, A. M\";i:12;s:12:\"TARASSOFF, P\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:148:\"Improvements in survival and Clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer : A randomized trial\";s:8:\"\u0000*\u0000place\";s:13:\"Baltimore, MD\";s:6:\"\u0000*\u0000pub\";s:29:\"Lippincott Williams & Wilkins\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:26:\"10.1200\/JCO.1997.15.6.2403\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:26:\"10.1200\/JCO.1997.15.6.2403\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:148:\"Improvements in survival and Clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer : A randomized trial\";s:9:\"\u0000*\u0000jtitle\";s:28:\"Journal of clinical oncology\";s:9:\"\u0000*\u0000stitle\";s:14:\"J. clin. oncol\";s:7:\"\u0000*\u0000date\";s:4:\"1997\";s:9:\"\u0000*\u0000volume\";s:2:\"15\";s:8:\"\u0000*\u0000issue\";s:1:\"6\";s:8:\"\u0000*\u0000spage\";s:4:\"2403\";s:8:\"\u0000*\u0000epage\";s:4:\"2413\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0732-183X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"BURRIS\";s:10:\"\u0000*\u0000aufirst\";s:4:\"H. A\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:13:{i:0;s:11:\"MOORE, M. J\";i:1;s:9:\"NELSON, R\";i:2;s:10:\"DORR, F. A\";i:3;s:14:\"STEPHENS, C. D\";i:4;s:14:\"VON HOFF, D. D\";i:5;s:11:\"ANDERSEN, J\";i:6;s:11:\"GREEN, M. R\";i:7;s:16:\"ROTHENBERG, M. L\";i:8;s:13:\"MODIANO, M. R\";i:9;s:12:\"CRIPPS, M. C\";i:10;s:14:\"PORTENOY, R. K\";i:11;s:15:\"STORNIOLO, A. M\";i:12;s:12:\"TARASSOFF, P\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:148:\"Improvements in survival and Clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer : A randomized trial\";s:8:\"\u0000*\u0000place\";s:13:\"Baltimore, MD\";s:6:\"\u0000*\u0000pub\";s:29:\"Lippincott Williams & Wilkins\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:26:\"10.1200\/JCO.1997.15.6.2403\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:148:\"Improvements in survival and Clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer : A randomized trial\";s:9:\"\u0000*\u0000jtitle\";s:28:\"Journal of clinical oncology\";s:9:\"\u0000*\u0000stitle\";s:14:\"J. clin. oncol\";s:7:\"\u0000*\u0000date\";s:4:\"1997\";s:9:\"\u0000*\u0000volume\";s:2:\"15\";s:8:\"\u0000*\u0000issue\";s:1:\"6\";s:8:\"\u0000*\u0000spage\";s:4:\"2403\";s:8:\"\u0000*\u0000epage\";s:4:\"2413\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0732-183X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"BURRIS\";s:10:\"\u0000*\u0000aufirst\";s:4:\"H. A\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:13:{i:0;s:11:\"MOORE, M. J\";i:1;s:9:\"NELSON, R\";i:2;s:10:\"DORR, F. A\";i:3;s:14:\"STEPHENS, C. D\";i:4;s:14:\"VON HOFF, D. D\";i:5;s:11:\"ANDERSEN, J\";i:6;s:11:\"GREEN, M. R\";i:7;s:16:\"ROTHENBERG, M. L\";i:8;s:13:\"MODIANO, M. R\";i:9;s:12:\"CRIPPS, M. C\";i:10;s:14:\"PORTENOY, R. K\";i:11;s:15:\"STORNIOLO, A. M\";i:12;s:12:\"TARASSOFF, P\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:148:\"Improvements in survival and Clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer : A randomized trial\";s:8:\"\u0000*\u0000place\";s:13:\"Baltimore, MD\";s:6:\"\u0000*\u0000pub\";s:29:\"Lippincott Williams & Wilkins\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:26:\"10.1200\/JCO.1997.15.6.2403\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:148:\"Improvements in survival and Clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer : A randomized trial\";s:9:\"\u0000*\u0000jtitle\";s:28:\"Journal of clinical oncology\";s:9:\"\u0000*\u0000stitle\";s:14:\"J. clin. oncol\";s:7:\"\u0000*\u0000date\";s:4:\"1997\";s:9:\"\u0000*\u0000volume\";s:2:\"15\";s:8:\"\u0000*\u0000issue\";s:1:\"6\";s:8:\"\u0000*\u0000spage\";s:4:\"2403\";s:8:\"\u0000*\u0000epage\";s:4:\"2413\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0732-183X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"BURRIS\";s:10:\"\u0000*\u0000aufirst\";s:4:\"H. A\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:13:{i:0;s:11:\"MOORE, M. J\";i:1;s:9:\"NELSON, R\";i:2;s:10:\"DORR, F. A\";i:3;s:14:\"STEPHENS, C. D\";i:4;s:14:\"VON HOFF, D. D\";i:5;s:11:\"ANDERSEN, J\";i:6;s:11:\"GREEN, M. R\";i:7;s:16:\"ROTHENBERG, M. L\";i:8;s:13:\"MODIANO, M. R\";i:9;s:12:\"CRIPPS, M. C\";i:10;s:14:\"PORTENOY, R. K\";i:11;s:15:\"STORNIOLO, A. M\";i:12;s:12:\"TARASSOFF, P\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:148:\"Improvements in survival and Clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer : A randomized trial\";s:8:\"\u0000*\u0000place\";s:13:\"Baltimore, MD\";s:6:\"\u0000*\u0000pub\";s:29:\"Lippincott Williams & Wilkins\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
